Results 211 to 220 of about 320,703 (320)

Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver. [PDF]

Viruses
Bao H, Murakami S, Tsuge M, Uchida T, Uchikawa S, Fujino H, Ono A, Murakami E, Kawaoka T, Miki D, Hayes CN, Oka S.   +11 more
europepmc   +1 more source

Neopterin as a Predictor of Response to Pegylated Interferon Therapy in Egyptian Patients with Chronic Hepatitis C Virus

, 2020
Heba Gamal Abdelaziz, Tamer Mahmoud El- Tantawy, Hanan Abd El-Mawgoud Attia, M. Hamed   +3 more
openalex   +2 more sources

Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study.

Clinical Infectious Diseases, 2014
D. Dieterich, J. Rockstroh, C. Orkin, F. Gutiérrez, M. Klein, J. Reynes, U. Shukla, Alan Jenkins, O. Lenz, S. Ouwerkerk-Mahadevan, M. Peeters, G. De La Rosa, L. Tambuyzer, W. Jessner   +13 more
semanticscholar   +1 more source

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B. [PDF]

Front Pharmacol
Wei N, Zheng B, Cai H, Li N, Yang J, Liu M.   +5 more
europepmc   +1 more source

Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial

, 2017
Lucia Masárová, Keyur P. Patel, Kate J. Newberry, Jorge E. Cortés, Gautam Borthakur, Marina Konopleva, Zeev Estrov, Hagop M. Kantarjian, Srđan Verstovšek   +8 more
openalex   +1 more source

Functional cure of a young child with chronic hepatitis B cirrhosis treated by pegylated interferon α combination therapy: A case report. [PDF]

Medicine (Baltimore)
Gan Y, Zhang H.
europepmc   +1 more source

Pegylated Interferon Pharmacokinetics and Self-Reported Depressive Symptoms During Antiviral Treatment for Chronic Hepatitis C

, 2014
D. Evon, D. Esserman, M. Howell, R. Ruffin   +3 more
openalex   +2 more sources

Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study. [PDF]

Virol J
Chang LJ, Hao CQ, Rao GR, Xu LL, Li J, Cheng Y, Zheng LJ, Wu CW, Chen HX, Chen ZR, Lian JQ, Wu SH, Luo LM, Zhang WL, Zhang Y.   +14 more
europepmc   +1 more source

Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation

, 2009
Jeremy Jones, Jonathan Shepherd, Louise Baxter, Elena Gospodarevskaya, D Hartwell, P Harris, Alison Price   +6 more
openalex   +2 more sources